Matthias Loehr - Mar 31, 2022 Form 3 Insider Report for PharmaCyte Biotech, Inc. (PMCB)

Role
Director
Signature
/s/ Matthias Loehr
Stock symbol
PMCB
Transactions as of
Mar 31, 2022
Transactions value $
$0
Form type
3
Date filed
4/11/2022, 09:00 AM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PMCB Common Stock 3K Mar 31, 2022 By BB Biomed Consulting GMBH F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of shares has been adjusted to reflect a one-for-1,500 reverse stock split of the Issuer's common stock effected on July 12, 2021.